Skip to main content
Screener/Healthcare/Biotechnology

ACAD — Acadia Pharmaceuticals Inc.

NASDAQ
$20.64-0.12 (-0.55%)
Mid CapUnder $50HealthcareHigh ROELow P/EUndervalued
$18.39
$30.96
$20.49
$21.01
EPS (TTM)$2.20
P/E Ratio9.38
Dividend Yield—
Market Cap$3.40B
Volume516K
Prev Close$20.76
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$268.1M$3.6M$0.0290.8%1.4%
Q4 '25$284.0M$273.6M$1.6090.8%96.3%
Q3 '25$278.6M$71.8M$0.4292.2%25.8%
Q2 '25$264.6M$26.7M$0.1692.2%10.1%
Q1 '25$244.3M$19.0M$0.1191.7%7.8%
Q4 '24$259.6M$143.7M$0.8691.6%55.4%
Q3 '24$250.4M$32.8M$0.2092.5%13.1%
Q2 '24$242.0M$33.4M$0.2092.5%13.8%
Get Your Daily Market Recap